
Sign up to save your podcasts
Or


🚨 New insights from the SCD-PROTECT Study! 🫀
In a nationwide German cohort of 19,598 patients with newly diagnosed NICM or MI/CAD, early use of the Wearable Cardioverter-Defibrillator (WCD) offered critical protection during the high-risk window of guideline-directed therapy initiation.
📉 Most shocks occurred in the first 200 days
📈 >50% improved LVEF beyond ICD threshold
🛡️ WCD = early shield + risk stratification tool
Let's rethink how we protect vulnerable hearts ❤️🔥
#Cardiology #SCD #HeartFailure #WCD #LVEF #ICD #ClinicalResearch #HeartHealth #CardiacArrest #PrecisionMedicine
By Dr RR Baliga, MD, MBA5
66 ratings
🚨 New insights from the SCD-PROTECT Study! 🫀
In a nationwide German cohort of 19,598 patients with newly diagnosed NICM or MI/CAD, early use of the Wearable Cardioverter-Defibrillator (WCD) offered critical protection during the high-risk window of guideline-directed therapy initiation.
📉 Most shocks occurred in the first 200 days
📈 >50% improved LVEF beyond ICD threshold
🛡️ WCD = early shield + risk stratification tool
Let's rethink how we protect vulnerable hearts ❤️🔥
#Cardiology #SCD #HeartFailure #WCD #LVEF #ICD #ClinicalResearch #HeartHealth #CardiacArrest #PrecisionMedicine

893 Listeners

3,374 Listeners

21,500 Listeners